MaxCyte, Inc. (MXCT) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	31.1M	33.0M	38.6M	41.3M	44.3M
Cost of Revenue	6.4M	6.2M	7.1M	4.7M	5.1M
Gross Profit	24.7M	26.8M	31.5M	36.5M	39.2M
Operating Expenses
R&D Expense	16.8M	20.8M	22.2M	23.8M	19.5M
SG&A Expense	38.9M	47.0M	56.4M	57.0M	44.5M
General & Admin Expense	24.7M	28.1M	29.7M	30.1M	25.8M
Selling & Marketing Expense	14.2M	18.9M	26.7M	27.0M	18.7M
Other Expenses	3.6M	4.2M	4.1M	4.0M	2.5M
Total Operating Expenses	59.3M	72.1M	82.7M	84.8M	66.5M
Cost and Expenses	65.7M	78.3M	89.8M	89.6M	71.6M
Operating Income (EBIT)	(34.7M)	(45.3M)	(51.2M)	(48.3M)	(27.4M)
Non-Operating
Interest Income	6.2M	7.3M	10.1M	10.4M	3.9M
Interest Expense	—	—	—	—	126.9K
Net Interest Income	6.2M	7.3M	10.1M	10.4M	3.8M
Other Non-Op Income/Expense	(975.0K)	655.0K	10.1M	10.4M	3.8M
Non-Operating Income (excl Interest)	975.0K	(655.0K)	(10.1M)	(10.4M)	(3.9M)
EBT (Pre-Tax Income)	(35.6M)	(44.6M)	(41.1M)	(37.9M)	(23.6M)
Income Tax Expense	—	—	—	—	—
Bottom Line
Net Income	(35.6M)	(44.6M)	(41.1M)	(37.9M)	(23.6M)
Earnings from Cont. Ops	(35.6M)	(44.6M)	(41.1M)	(37.9M)	(23.6M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(35.6M)	(44.6M)	(41.1M)	(37.9M)	(23.6M)
Per Share
Basic EPS	($0.33)	($0.42)	($0.39)	($0.37)	($0.19)
Diluted EPS	($0.33)	($0.42)	($0.39)	($0.37)	($0.19)
Revenue Per Share	$0.29	$0.31	$0.37	$0.40	$0.44
Shares
Basic Shares Outstanding	106.8M	106.4M	104.8M	103.3M	101.7M
Diluted Shares Outstanding	106.8M	106.4M	104.8M	103.3M	101.7M
Profitability Metrics
EBITDA	(32.5M)	(39.5M)	(36.3M)	(33.8M)	(20.7M)
D&A	3.2M	5.1M	4.8M	4.2M	2.7M
EBIT	(35.6M)	(44.6M)	(41.1M)	(37.9M)	(23.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026